BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wong CR, Nguyen MH, Lim JK. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(37): 8294-8303 [PMID: 27729736 DOI: 10.3748/wjg.v22.i37.8294]
URL: https://www.wjgnet.com/1007-9327/full/v22/i37/8294.htm
Number Citing Articles
1
Danny Orabi, Nathan A. Berger, J. Mark Brown. Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to ChemopreventionCancers 2021; 13(14): 3473 doi: 10.3390/cancers13143473
2
C. R. Wong, B. Njei, M. H. Nguyen, A. Nguyen, J. K. Lim. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non‐alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics 2017; 46(11-12): 1061 doi: 10.1111/apt.14342
3
Donghee Kim, Osama Siddique, Brandon J. Perumpail, Aijaz Ahmed. Clinical Epidemiology of Chronic Liver Diseases2019; : 211 doi: 10.1007/978-3-319-94355-8_14
4
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease researchWorld Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
5
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive ApproachesDiagnostics 2022; 12(2): 407 doi: 10.3390/diagnostics12020407
6
Veeravich Jaruvongvanich, Karn Wijarnpreecha, Patompong Ungprasert. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort studyClinics and Research in Hepatology and Gastroenterology 2017; 41(6): 629 doi: 10.1016/j.clinre.2017.03.010
7
Antonella Cammarota, Antonio D’Alessio, Tiziana Pressiani, Lorenza Rimassa, Nicola Personeni. Systemic Treatment for Older Patients with Unresectable Hepatocellular CarcinomaDrugs & Aging 2021; 38(7): 579 doi: 10.1007/s40266-021-00871-5
8
Zobair M. Younossi, Kathleen E. Corey, Naim Alkhouri, Mazen Noureddin, Ira Jacobson, Brian Lam, Stephen Clement, Rita Basu, Stuart C. Gordon, Natarajan Ravendhra, Puneet Puri, Mary Rinella, Peter Scudera, Ashwani K. Singal, Linda Henry. Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practicesAlimentary Pharmacology & Therapeutics 2020; 52(3): 513 doi: 10.1111/apt.15830
9
Shang-Shyue Tsai, Chun-Ta Hsu, ChunYuh Yang. Risk of death from liver cancer in relation to long-term exposure to fine particulate air pollution in TaiwanJournal of Toxicology and Environmental Health, Part A 2023; 86(5): 135 doi: 10.1080/15287394.2023.2168225
10
Osmanuddin Ahmed, Lisa Liu, Antony Gayed, Amanjit Baadh, Mikin Patel, Jordan Tasse, Ulku Turba, Bulent Arslan. The Changing Face of Hepatocellular Carcinoma: Forecasting Prevalence of Nonalcoholic Steatohepatitis and Hepatitis C CirrhosisJournal of Clinical and Experimental Hepatology 2019; 9(1): 50 doi: 10.1016/j.jceh.2018.02.006
11
Eunüs S. Ali, Grigori Y. Rychkov, Greg J. Barritt. Store-Operated Ca²⁺ Entry (SOCE) PathwaysAdvances in Experimental Medicine and Biology 2017; 993: 595 doi: 10.1007/978-3-319-57732-6_30
12
Wen-Yong Wu, Si-Qi Tao, Xiao-Nan Wang, Peter E Lobie, Zheng-Sheng Wu. XIAP 3′-untranslated region serves as a competitor for HMGA2 by arresting endogenous let-7a-5p in human hepatocellular carcinomaTumor Biology 2017; 39(7): 101042831771957 doi: 10.1177/1010428317719578
13
P. Wainwright, E. Scorletti, C. D. Byrne. Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and PathogenesisCurrent Diabetes Reports 2017; 17(4) doi: 10.1007/s11892-017-0851-x
14
Bin Zhang, Chenyang Zhang, Xuelian Zhang, Nannan Li, Zhengqi Dong, Guibo Sun, Xiaobo Sun. Atorvastatin promotes AMPK signaling to protect against high fat diet‑induced non‑alcoholic fatty liver in golden hamstersExperimental and Therapeutic Medicine 2020;  doi: 10.3892/etm.2020.8465
15
Mélanie Simoes Eugénio, Muhammad Farooq, Sarah Dion, Christelle Devisme, Céline Raguenes-Nicol, Claire Piquet-Pellorce, Michel Samson, Marie-Thérèse Dimanche-Boitrel, Jacques Le Seyec. Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune ResponseCancers 2020; 12(6): 1491 doi: 10.3390/cancers12061491
16
Darren Jun Hao Tan, Cheng Han Ng, Snow Yunni Lin, Xin Hui Pan, Phoebe Tay, Wen Hui Lim, Margaret Teng, Nicholas Syn, Grace Lim, Jie Ning Yong, Jingxuan Quek, Jieling Xiao, Yock Young Dan, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark D Muthiah, Rohit Loomba, Daniel Q Huang. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysisThe Lancet Oncology 2022; 23(4): 521 doi: 10.1016/S1470-2045(22)00078-X
17
Miao Fang, Min Yao, Jie Yang, Wen-Jie Zheng, Li Wang, Deng-Fu Yao. Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesisWorld Journal of Gastrointestinal Oncology 2020; 12(1): 66-76 doi: 10.4251/wjgo.v12.i1.66
18
Erin M. Sadler, Neil Mehta, Mamatha Bhat, Anand Ghanekar, Paul D. Greig, David R. Grant, Francis Yao, Gonzalo Sapisochin. Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular CarcinomaTransplantation 2018; 102(4): 640 doi: 10.1097/TP.0000000000002043
19
Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho. KASL clinical practice guidelines: Management of nonalcoholic fatty liver diseaseClinical and Molecular Hepatology 2021; 27(3): 363 doi: 10.3350/cmh.2021.0178
20
Changes in body composition and low blood urea nitrogen level related to an increase in the prevalence of fatty liver over 20 years: A cross‐sectional studyHepatology Research 2021; 51(5): 570 doi: 10.1111/hepr.13631
21
Bou-Zenn Lin, Tsung-Jung Lin, Chih-Lin Lin, Li-Ying Liao, Ting-An Chang, Buo-Jia Lu, Kuan-Yang Chen. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver diseaseJournal of the Chinese Medical Association 2021; 84(6): 606 doi: 10.1097/JCMA.0000000000000530
22
Arjun Gupta, Avash Das, Kaustav Majumder, Nivedita Arora, Helen G. Mayo, Preet P. Singh, Muhammad S. Beg, Siddharth Singh. Obesity is Independently Associated With Increased Risk of Hepatocellular Cancer–related MortalityAmerican Journal of Clinical Oncology 2018; 41(9): 874 doi: 10.1097/COC.0000000000000388
23
Rina So, Jie Chen, Amar J. Mehta, Shuo Liu, Maciej Strak, Kathrin Wolf, Ulla A. Hvidtfeldt, Sophia Rodopoulou, Massimo Stafoggia, Jochem O. Klompmaker, Evangelia Samoli, Ole Raaschou‐Nielsen, Richard Atkinson, Mariska Bauwelinck, Tom Bellander, Marie‐Christine Boutron‐Ruault, Jørgen Brandt, Bert Brunekreef, Giulia Cesaroni, Hans Concin, Francesco Forastiere, Carla H. van Gils, John Gulliver, Ole Hertel, Barbara Hoffmann, Kees de Hoogh, Nicole Janssen, Youn‐hee Lim, Rudi Westendorp, Jeanette T. Jørgensen, Klea Katsouyanni, Matthias Ketzel, Anton Lager, Alois Lang, Petter L. Ljungman, Patrik K.E. Magnusson, Gabriele Nagel, Mette K. Simonsen, Göran Pershagen, Raphael S. Peter, Annette Peters, Matteo Renzi, Debora Rizzuto, Torben Sigsgaard, Danielle Vienneau, Gudrun Weinmayr, Gianluca Severi, Daniela Fecht, Anne Tjønneland, Karin Leander, Gerard Hoek, Zorana J. Andersen. Long‐term exposure to air pollution and liver cancer incidence in six European cohortsInternational Journal of Cancer 2021; 149(11): 1887 doi: 10.1002/ijc.33743
24
Benjamin Buchard, Camille Teilhet, Natali Abeywickrama Samarakoon, Sylvie Massoulier, Juliette Joubert-Zakeyh, Corinne Blouin, Christelle Reynes, Robert Sabatier, Anne-Sophie Biesse-Martin, Marie-Paule Vasson, Armando Abergel, Aicha Demidem. Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis SeverityMetabolites 2021; 11(1): 54 doi: 10.3390/metabo11010054
25
Arnaud Tête, Isabelle Gallais, Muhammad Imran, Martine Chevanne, Marie Liamin, Lydie Sparfel, Simon Bucher, Agnès Burel, Normand Podechard, Brice M.R. Appenzeller, Bernard Fromenty, Nathalie Grova, Odile Sergent, Dominique Lagadic-Gossmann. Mechanisms involved in the death of steatotic WIF-B9 hepatocytes co-exposed to benzo[a]pyrene and ethanol: a possible key role for xenobiotic metabolism and nitric oxideFree Radical Biology and Medicine 2018; 129: 323 doi: 10.1016/j.freeradbiomed.2018.09.042
26
Doris Kaltenecker, Madeleine Themanns, Kristina M. Mueller, Katrin Spirk, Tobias Suske, Olaf Merkel, Lukas Kenner, Andreia Luís, Andrey Kozlov, Johannes Haybaeck, Mathias Müller, Xiaonan Han, Richard Moriggl. Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progressionCytokine 2019; 124: 154569 doi: 10.1016/j.cyto.2018.10.010
27
Sirui Zhou, Weijian Zhu, Hehua Guo, Yalan Nie, Jiazheng Sun, Ping Liu, Yulan Zeng. Microbes for lung cancer detection: feasibility and limitationsFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1361879
28
Dan L. Longo, Anna M. Diehl, Christopher Day. Cause, Pathogenesis, and Treatment of Nonalcoholic SteatohepatitisNew England Journal of Medicine 2017; 377(21): 2063 doi: 10.1056/NEJMra1503519
29
Marie Pedersen, Zorana J. Andersen, Massimo Stafoggia, Gudrun Weinmayr, Claudia Galassi, Mette Sørensen, Kirsten T. Eriksen, Anne Tjønneland, Steffen Loft, Andrea Jaensch, Gabriele Nagel, Hans Concin, Ming-Yi Tsai, Sara Grioni, Alessandro Marcon, Vittorio Krogh, Fulvio Ricceri, Carlotta Sacerdote, Andrea Ranzi, Ranjeet Sokhi, Roel Vermeulen, Kees de Hoogh, Meng Wang, Rob Beelen, Paolo Vineis, Bert Brunekreef, Gerard Hoek, Ole Raaschou-Nielsen. Ambient air pollution and primary liver cancer incidence in four European cohorts within the ESCAPE projectEnvironmental Research 2017; 154: 226 doi: 10.1016/j.envres.2017.01.006
30
Laura Iogna Prat, Emmanuel A. Tsochatzis. The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD)Hormones 2018; 17(2): 219 doi: 10.1007/s42000-018-0021-9
31
B. Huang, J. Bao, Y.-R. Cao, H.-F. Gao, Y. Jin. Cytochrome P450 1A1 (CYP1A1) Catalyzes Lipid Peroxidation of Oleic Acid-Induced HepG2 CellsBiochemistry (Moscow) 2018; 83(5): 595 doi: 10.1134/S0006297918050127
32
Margarita N. German, Megan K. Lutz, Perry J. Pickhardt, Richard J. Bruce, Adnan Said. Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver DiseaseJournal of Clinical Gastroenterology 2020; 54(8): 733 doi: 10.1097/MCG.0000000000001260
33
V. V. Pavan Kedar Mukthinuthalapati, Vikash Sewram, Ntokozo Ndlovu, Stephen Kimani, Ashraf Omar Abdelaziz, Elizabeth Yu Chiao, Ghassan K. Abou-Alfa. Hepatocellular Carcinoma in Sub-Saharan AfricaJCO Global Oncology 2021; (7): 756 doi: 10.1200/GO.20.00425
34
Boushra Bathish, Holly Robertson, John F. Dillon, Albena T. Dinkova-Kostova, John D. Hayes. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2Free Radical Biology and Medicine 2022; 188: 221 doi: 10.1016/j.freeradbiomed.2022.06.226
35
Xiaoyu Liu, Wenhui Ju, Chuanhong Huo, Shuhong Zhang, Xingang Wang, Kai Huang. Overweight and Obesity as Independent Factors for Increased Risk of Hepatocellular Cancer-Related Mortality: A Meta-AnalysisJournal of the American College of Nutrition 2021; 40(3): 287 doi: 10.1080/07315724.2020.1751007
36
Kathryn E. Royse, Hashem B. El-Serag, Liang Chen, Donna L. White, Lauren Hale, Haleh Sangi-Haghpeykar, Li Jiao. Sleep Duration and Risk of Liver Cancer in Postmenopausal Women: The Women's Health Initiative StudyJournal of Women's Health 2017; 26(12): 1270 doi: 10.1089/jwh.2017.6412
37
Cristiana Porcu, Laura Antonucci, Barbara Barbaro, Barbara Illi, Sergio Nasi, Maurizio Martini, Anna Licata, Luca Miele, Antonio Grieco, Clara Balsano. Copper/MYC/CTR1 interplay: a dangerous relationship in hepatocellular carcinomaOncotarget 2018; 9(10): 9325 doi: 10.18632/oncotarget.24282
38
Roberto Rodriguez-Echevarria, Jose Macias-Barragan, Marcela Parra-Vargas, Judith Rebeca Davila-Rodriguez, Eduardo Amezcua-Galvez, Juan Armendariz-Borunda. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in miceWorld Journal of Gastroenterology 2018; 24(4): 461-474 doi: 10.3748/wjg.v24.i4.461
39
Mamatha Bhat, Elisa Pasini, Chiara Pastrello, Marc Angeli, Cristina Baciu, Mark Abovsky, Angella Coffee, Oyedele Adeyi, Max Kotlyar, Igor Jurisica. Estrogen Receptor 1 Inhibition of Wnt/β-Catenin Signaling Contributes to Sex Differences in HepatocarcinogenesisFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.777834
40
Zobair M. Younossi, Linda Henry. Fatty Liver Through the Ages: Nonalcoholic SteatohepatitisEndocrine Practice 2022; 28(2): 204 doi: 10.1016/j.eprac.2021.12.010
41
Jing Liang, Jianhui Zhu, Mengmeng Wang, Amit G. Singal, Mobolaji Odewole, Sofia Kagan, Veronica Renteria, Suyu Liu, Neehar D. Parikh, David M. Lubman. Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different EtiologiesScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-48043-1
42
Natalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, Dimitrios Tsilingiris, Faidon Magkos, Theodora Stratigou, Dimitris Kounatidis, Maria Dalamaga. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and PerspectivesBiomolecules 2021; 12(1): 56 doi: 10.3390/biom12010056
43
Lourianne Nascimento CAVALCANTE, Maria Gabriela Fernandes DEZAN, Cláudio Luiz da S L PAZ, André Castro LYRA. RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASEArquivos de Gastroenterologia 2022;  doi: 10.1590/s0004-2803.202204000-93
44
Yi Shen, Harvey Risch, Lingeng Lu, Xiaomei Ma, Melinda L. Irwin, Joseph K. Lim, Tamar Taddei, Karen Pawlish, Antoinette Stroup, Robert Brown, Zhanwei Wang, Wei Jia, Linda Wong, Susan T. Mayne, Herbert Yu. Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control studyCancer Causes & Control 2020; 31(4): 321 doi: 10.1007/s10552-020-01277-1
45
EmadA Awad, TarekM Youssef, MohamedO Aly, AzzaA R. Saab. Clinical utility of serum chromogranin A as a marker of hepatocellular carcinoma in chronic hepatitis patientsThe Egyptian Journal of Laboratory Medicine 2020; 32(3): 76 doi: 10.4103/ejolm.ejolm_10_21
46
Changting Meng, Chunmei Bai, Thomas D. Brown, Leroy E. Hood, Qiang Tian. Human Gut Microbiota and Gastrointestinal CancerGenomics, Proteomics & Bioinformatics 2018; 16(1): 33 doi: 10.1016/j.gpb.2017.06.002
47
Huajun Wu, Zhiwei Zhong, Anji Wang, Chunhui Yuan, Ke Ning, Huanhuan Hu, Chao Wang, Xiangbao Yin. LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cellsCancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01354-0
48
Doris Kaltenecker, Madeleine Themanns, Kristina M. Mueller, Katrin Spirk, Nicole Golob-Schwarzl, Katrin Friedbichler, Lukas Kenner, Johannes Haybaeck, Richard Moriggl. STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in miceCytokine 2019; 124: 154573 doi: 10.1016/j.cyto.2018.10.014
49
David Bernstein, Alexander J. Kovalic. Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]Metabolism Open 2022; 13: 100158 doi: 10.1016/j.metop.2021.100158
50
Marco Rossato, Angelo Di Vincenzo, Claudio Pagano, Hamza El Hadi, Roberto Vettor. The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief ReviewCells 2020; 9(4): 1047 doi: 10.3390/cells9041047
51
Seung-Cheol Lee, Seung-Cheol Jee, Min Kim, Soee Kim, Min Kyoung Shin, Yunkyung Kim, Jung-Suk Sung. Curcumin Suppresses the Lipid Accumulation and Oxidative Stress Induced by Benzo[a]pyrene Toxicity in HepG2 CellsAntioxidants 2021; 10(8): 1314 doi: 10.3390/antiox10081314
52
Emilio De Raffele. Liver Diseases2020; : 341 doi: 10.1007/978-3-030-24432-3_31
53
Chinasa Valerie Olovo, Xinxiang Huang, Xueming Zheng, Min Xu. Faecal microbial biomarkers in early diagnosis of colorectal cancerJournal of Cellular and Molecular Medicine 2021; 25(23): 10783 doi: 10.1111/jcmm.17010
54
Valeria Abbate, Margherita Marcantoni, Felice Giuliante, Fabio Vecchio, Ilaria Gatto, Caterina Mele, Antonio Saviano, Damiano Arciuolo, Eleonora Gaetani, Maria Ferrari, Igor Giarretta, Francesco Ardito, Laura Riccardi, Alberto Nicoletti, Francesca Ponziani, Antonio Gasbarrini, Maurizio Pompili, Roberto Pola. HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver ResectionInternational Journal of Molecular Sciences 2017; 18(5): 1043 doi: 10.3390/ijms18051043
55
Yonah B. Esterson, Gregory M. Grimaldi. Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisClinics in Liver Disease 2018; 22(1): 93 doi: 10.1016/j.cld.2017.08.005
56
Stavros Kalpadakis, Dimitra Sifaki-Pistolla, Emmanouil K. Symvoulakis, Panagiotis Kelefiotis-Stratidakis, Lambros Vamvakas, Dimitrios Mavroudis, Christos Lionis. Reporting Liver Cancer Trends in the Island of Crete, Greece: Results from a Geo-Epidemiological StudyInternational Journal of Environmental Research and Public Health 2022; 19(16): 10166 doi: 10.3390/ijerph191610166
57
Jose Tadeu Stefano, Fernanda de Mello Malta, Priscila Brizola de Campos, Pedro Fernandes Andrade, Denise Cerqueira Paranaguá-Vezzozo, Flair Jose Carrilho, Claudia P. Oliveira. NAFLD and NASH2020; : 191 doi: 10.1007/978-3-030-37173-9_11
58
Simon Bucher, Arnaud Tête, Normand Podechard, Marie Liamin, Dounia Le Guillou, Martine Chevanne, Cédric Coulouarn, Muhammad Imran, Isabelle Gallais, Morgane Fernier, Quentin Hamdaoui, Marie-Anne Robin, Odile Sergent, Bernard Fromenty, Dominique Lagadic-Gossmann. Co-exposure to benzo[a]pyrene and ethanol induces a pathological progression of liver steatosis in vitro and in vivoScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24403-1
59
Masamichi Hayashi, Suguru Yamada, Hiroshi Tanabe, Hideki Takami, Yoshikuni Inokawa, Fuminori Sonohara, Dai Shimizu, Norifumi Hattori, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. High Serum Uric Acid Levels Could Be a Risk Factor of Hepatocellular Carcinoma RecurrencesNutrition and Cancer 2021; 73(6): 996 doi: 10.1080/01635581.2020.1779758
60
Yucel Aydin, Ali Riza Koksal, Paul Thevenot, Srinivas Chava, Zahra Heidari, Dong Lin, Tyler Sandow, Krzysztof Moroz, Mansour A Parsi, John Scott, Ari Cohen, Srikanta Dash. Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver CirrhosisJournal of Hepatocellular Carcinoma 2021; : 1579 doi: 10.2147/JHC.S327339
61
Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez, Haiping Hao. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-InflammationDrug Metabolism and Disposition 2018; 46(9): 1310 doi: 10.1124/dmd.118.082008
62
Divya Saro Varghese, Bassam R. Ali. Pathological Crosstalk Between Oxidized LDL and ER Stress in Human Diseases: A Comprehensive ReviewFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.674103
63
Koen C. van Son, Lars Verschuren, Roeland Hanemaaijer, Helen Reeves, R. Bart Takkenberg, Joost P. H. Drenth, Maarten E. Tushuizen, Adriaan G. Holleboom. Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver DiseaseCancers 2023; 15(4): 1308 doi: 10.3390/cancers15041308
64
Claudia Veltkamp, Shuai Lan, Eleni Korompoki, Karl-Heinz Weiss, Hartmut Schmidt, Helmut K. Seitz. Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel DiseaseJournal of Clinical Medicine 2022; 11(9): 2623 doi: 10.3390/jcm11092623
65
Brandon J Perumpail, Muhammad Ali Khan, Eric R Yoo, George Cholankeril, Donghee Kim, Aijaz Ahmed. Clinical epidemiology and disease burden of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2017; 23(47): 8263-8276 doi: 10.3748/wjg.v23.i47.8263
66
Daniel Schuette, Lauren M. Moore, Marie E. Robert, Tamar H. Taddei, Barbara E. Ehrlich. Hepatocellular Carcinoma Outcome Is Predicted by Expression of Neuronal Calcium Sensor 1Cancer Epidemiology, Biomarkers & Prevention 2018; 27(9): 1091 doi: 10.1158/1055-9965.EPI-18-0167
67
Min Yao, Wenjie Zheng, Li Wang, Miao Fang, Zhizhen Dong, Dengfu Yao. Neoplasm2018;  doi: 10.5772/intechopen.77400
68
Mie Mochizuki, Yasuhiro Nakayama, Kazumasa Sato, Takeshi Inukai. Focal nodular hyperplasia‐like lesion in a girl with obesity and fatty liverPediatrics International 2022; 64(1) doi: 10.1111/ped.15392
69
Rohit Loomba, Joseph K. Lim, Heather Patton, Hashem B. El-Serag. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert ReviewGastroenterology 2020; 158(6): 1822 doi: 10.1053/j.gastro.2019.12.053
70
Sathish Venugopal, Ravneet k Dhanoa, Tharun Yadhav Selvamani, Shoukrie I Shoukrie, Anam Zahra, Jyothirmai Malla, Ramaneshwar Selvaraj, Ranim K Hamouda, Lubna Mohammed. Does Type 2 Diabetes Increase the Risk of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease Patients: A Systematic ReviewCureus 2023;  doi: 10.7759/cureus.36079